Synapse - Find an Expert

10207 Results

Rising incidence and racial disparities of early-onset endometrial cancer in the United States, 1995-2018

Meeting Abstract

Habeshian, T. S.; Liu, L.; Zhang, J. J.; Du, M.; De Vivo, I.; Setiawan, V. W.
Cancer Epidemiology Biomarkers and Prevention (2023)

Fulltext@MSK | Save

HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplant cyclophosphamide improves clinical outcomes for racial and ethnic minority patients with hematologic malignancies

Meeting Abstract

Jimenez, A. M. J.; Iyer, S.; Komanduri, K.; Brown, S.; Wang, T.; Chinapen, S.; Pereira, D.; Devlin, S.; Goodman, M.; Beitinjaneh, A.; more...
Cancer Epidemiology Biomarkers and Prevention (2023)

Fulltext@MSK | Save

Relationship between clinician-measured health outcomes and patient-reported outcomes following head neck radiation therapy

Meeting Abstract

Singh, A.; Long, S. M.; Tin, Amy L.; Vickers, A. J.; Cracchiolo, J. R.; Lee, N. Y.; Yom, S. K.; Randazzo, J. R.; Huryn, J. M.; Estilo, C. L.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology (2023)

Fulltext@MSK | Save

Cardiac safety study for reduced cardiotoxicity surveillance in patients with HER2-positive breast cancer

Meeting Abstract

Yu, A. F.; Dang, C.; Jorgensen, J.; Liu, J. E.; Moskowitz, C.; Oligino, E. J.; Oeffinger, K. C.; Steingart, R. M.
Journal of the American College of Cardiology (2023)

Fulltext@MSK | Save

Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Rao, A.; Heller, G.; Ryan, C. J.; VanderWeele, D. J.; Lewis, L. D.; Tan, A.; Watt, C.; Chen, R. C.; Kohli, M.; Barata, P. C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade

Meeting Abstract

Reese, S. W.; Jiang, H.; Kuo, F.; Wu, C. Y.; Vuong, L.; Mascareno, E.; Oparanozie, A.; Motzer, R. J.; Voss, M. H.; Reznik, E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Correlating HLA variants and the emergence of immune-related adverse events (irAEs) from ipilimumab/nivolumab (I/N) in patients (pts) treated on CheckMate 214

Meeting Abstract

Voss, M. H.; Shah, N. J.; Kalvin, H. L.; Lihm, J.; Li, H.; Kotecha, R. R.; Jarchum, I.; Vemula, S. V.; Gupta, S.; Motzer, R. J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)

Meeting Abstract

Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)